Physician profile
Marcus Wong
NPI 1245723311
$9,254.25
in general payments reported to CMS, 2019-2025
21 companies · $4,804 in 2025
The $4,804 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $595 · 2021: $528 · 2022: $1,050 · 2023: $267 · 2024: $706 · 2025: $4,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,213 · Food and Beverage: $2,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,212.63 |
| Food and Beverage | $2,564.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,648.48 | 2019-2025 | Surpass Evolve, Target, Trevo |
| Balt USA, LLC | $1,981.62 | 2025 | Optima Coil System, Carrier Delivery Catheter, Raptor Aspiration Catheter |
| Zimmer Biomet Holdings, INC. | $935.51 | 2019-2020 | |
| Microvention, INC. | $637.33 | 2025 | Stent, Web Aneurysm Embolization System, Eric Retrieval Device |
| Baxter Healthcare | $478.75 | 2024-2025 | Floseal |
| Si-Bone, INC. | $378.25 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $353.95 | 2020-2021 | |
| Integra Lifesciences Corporation | $320.87 | 2022-2024 | Medihoney, Biofix, Biodoptix |
| Medtronic, INC. | $285.09 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $188.16 | 2019-2020 | |
| Medtronic USA, INC. | $161.25 | 2020 | |
| Irras USA, INC. | $145.32 | 2023 | |
| Carlsmed, INC. | $133.36 | 2022 | |
| Revance Therapeutics, INC. | $126.78 | 2024 | Daxxify |
| Depuy Synthes Sales INC. | $124.88 | 2019-2025 | Embotrap, Cerepak Uniform, Cerebase |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $103.38 | 2022 | |
| Kls-Martin L.P. | $100.00 | 2022 | |
| Medinc of Texas | $62.92 | 2024 | |
| Cardiva Medical, INC. | $49.86 | 2025 | Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $21.20 | 2023 | Andexxa |
| Merz North America, INC. | $17.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.